文献速递消化道肿瘤与早癌消化内镜

基于超声内镜的早期胃癌淋巴结转移风险评估模型的建立与验证

Establishment and validation of a risk score model based on EUS: assessment of lymph node metastasis in early gastric cancer.
PubMed 文献 · Gastrointest Endosc · 2024-04-29

本研究回顾性分析超声内镜(EUS)对早期胃癌淋巴结转移的检测效能,并基于肿瘤大小≥20 mm、淋巴结≥10 mm、体重指数≥24 kg/m2及CT显示淋巴结转移等术前危险因素建立7分风险评估模型。EUS总体准确率为85.3%,但敏感度(29.2%)和阳性预测值(38.7%)较低。开发集和验证集受试者工作特征曲线下面积分别为0.842和0.837,敏感度分别为64%和79%。

要点

  • EUS识别早期胃癌淋巴结转移总体准确率85.3%,敏感度29.2%,阳性预测值38.7%。
  • 基于肿瘤大小≥20 mm、淋巴结≥10 mm、BMI≥24 kg/m2及CT淋巴结转移建立7分风险评分模型。
  • 模型开发集与验证集AUC分别为0.842和0.837,敏感度分别为64%和79%。

核心结论

  • 开发了基于术前因素的实用风险评分模型,帮助EUS预测早期胃癌患者淋巴结转移,以指导选择最佳治疗方式。

研究设计与样本

  • 回顾性分析EUS检测早期胃癌患者淋巴结转移的有效性,通过二元logistic回归分析确定独立危险因素并建立术前预测淋巴结转移的风险评分模型,随后进行验证,并生成开发集和验证集的受试者工作特征曲线。

主要发现

  • EUS识别淋巴结转移的总体准确率为85.3%,敏感度为29.2%,阳性预测值为38.7%。
  • 术前淋巴结转移危险因素包括肿瘤大小≥20 mm、淋巴结≥10 mm、体重指数≥24 kg/m2以及CT扫描显示淋巴结转移。
  • 建立7分风险评分模型评估淋巴结转移可能性。
  • 开发集受试者工作特征曲线下面积为0.842,验证集为0.837;敏感度分别为64%和79%。

关键数值与推荐

  • 风险评分模型总分7分,基于肿瘤大小≥20 mm、淋巴结≥10 mm、体重指数≥24 kg/m2及CT显示淋巴结转移等术前因素。
  • 开发集AUC 0.842,敏感度64%;验证集AUC 0.837,敏感度79%。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Lymph node metastasis significantly affects the prognosis of early gastric cancer patients. EUS plays a crucial role in the preoperative assessment of early gastric cancer. This study evaluated the efficacy of EUS in identifying lymph node metastasis in early gastric cancer patients and developed a risk score model to aid in choosing the best treatment options. METHODS: We retrospectively analyzed the effectiveness of EUS for detecting lymph node metastasis in early gastric cancer patients. A risk score model for predicting lymph node metastasis preoperatively was created using independent risk factors identified through binary logistic regression analysis and subsequently validated. Receiver operating characteristic curves were generated for both the development and validation cohorts. RESULTS: The overall accuracy of EUS in identifying lymph node metastasis was 85.3%, although its sensitivity (29.2%) and positive predictive value (38.7%) were relatively low. Patients were categorized based on preoperative risk factors for lymph node metastasis, including tumor size of ≥20 mm, lymph nodes of ≥10 mm, body mass index of ≥24 kg/m2, and lymph node metastasis on CT scans. A 7-point risk score model was developed to assess the likelihood of lymph node metastasis. The areas under the receiver operating characteristic curve for the development and validation sets were 0.842 and 0.837, respectively, with sensitivities of 64% and 79%, respectively. CONCLUSIONS: We developed a practical risk score model based on preoperative factors to help EUS predict lymph node metastasis in early gastric cancer patients, guiding the selection of optimal treatment approaches for these patients.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Liu S, Zhang M, Yang Y, et al. Establishment and validation of a risk score model based on EUS: assessment of lymph node metastasis in early gastric cancer. Gastrointest Endosc. 2024. PMID: 38692516. doi:10.1016/j.gie.2024.04.2903

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。